ScholarIQanswers from OpenAlex

An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL

PaperCitations, authors & open-access status

An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL is a paper indexed in ScholarIQ from OpenAlex.

How many citations does An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL have?

ScholarIQcitation count

An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL has 27 citations in the OpenAlex counts ScholarIQ stores.

When was An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL published?

ScholarIQyear

An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL has 2019 year in the ScholarIQ index.

What is the open-access status of An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL?

ScholarIQoa status

An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL has closed oa status in the ScholarIQ index.

What is the DOI of An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL?

ScholarIQdoi

The DOI for An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL is on the source record.

What is the PMID of An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL?

ScholarIQpmid

The PMID for An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL is on the source record.

What is the OpenAlex record for An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL?

ScholarIQopenalex

The OpenAlex for An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial